DeviceTalks Podcast Network

In this special episode of the DeviceTalks Women in MedTech podcast, Host Kayleen Brown brings listeners inside the 6th Women in MedTech Breakfast held May 4 at DeviceTalks Minnesota for a powerful keynote panel on “The Art of High-Stakes Decision-Making.”

The conversation features Cat Jennings, SVP and President of Vascular Therapies at Boston Scientific; Laura Stoltenberg, President and CEO of Cryosa; and Marcie DeWalt, Chief Human Resources Officer at Provation. Together, they explore what it really takes to lead through uncertainty. From billion-dollar M&A and clinical trial bets to organizational transformations and personal career pivots, the panelists share candid stories about navigating moments where the pressure is real and the outcomes are uncertain.

Throughout the discussion, the leaders examine the balance between data and intuition, the importance of stakeholder alignment, and how to develop the conviction to move forward when there is no "undo" button. Whether managing portfolio strategy at a strategic or navigating the growth of a startup, this episode offers practical frameworks for making decisions that shape companies, careers, and patient care.

Kayleen also welcomes Heather Hudnut Page and Archana Desai in-studio to discuss the inspiration behind this year’s theme and how the Women in MedTech Breakfast continues creating space for authentic leadership conversations and community-building across the industry.

Thank you to Aptyx for sponsoring the Women in MedTech Breakfast at DeviceTalks Minnesota and supporting these essential industry conversations!! Visit https://www.aptyx.com to learn more.

Join us May 27-28th at DeviceTalks Boston for the next Women in MedTech Breakfast featuring Dr. Carla Goulart Peron, Chief Medical Officer for Philips to discuss designing MedTech for reality. https://boston.devicetalks.com/

***

Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:00:00) - Intro + DeviceTalks Boston 2026 preview
(00:04:07) - In-studio guests: Heather Hudnut Page and Archana Desai
(00:22:53) - Kayleen on Artemis II & High-Stakes Decision Making
(00:25:40) - Keynote Panel: Cat Jennings, Laura Stoltenberg, and Marcie DeWalt
(00:33:30) - M&A, Reorganizations, and Tough Business Decisions
(00:50:00) - Clinical Trial Risks, Innovation Bets, and Portfolio Strategy
(01:01:25) - Final Leadership Lessons: How Great Leaders Make High-Stakes Decisions
(01:05:03) - Closing Remarks and Thank You to Aptyx

In this special DeviceTalks Weekly Podcast episode, Host Tom Salemi previews the biggest conversations, technologies, and innovators heading to DeviceTalks Boston on May 27–28 at the Boston Convention & Exhibition Center.

First, Tom Salemi and Mike Moore, partner at The Mullings Group, visits with Christian Howell, CEO of Cognito Therapeutics. Howell will be speaking at DeviceTalks Boston about the neuro company’s clinical, fund-raising and partnering success.

Howell also shares insights into Cognito’s partnerships with research institutions and the future of noninvasive therapies for neurodegenerative disease. He’ll be among the many speakers address Innovation & Investment at the conference, with others including the MedTech Innovator Open Rounds sessions and venture capital investors including Abby Hunter-Syed of Olympus Innovation Ventures and Maria Berkman, MD, of Vensana Capital.

Tom and Holly Scott also speak with Dr. Sarah Matt, author of Borderless Healthcare Revolution, about the challenges of connected health adoption and why many health-tech pilots fail to scale. Matt previews her DeviceTalks Boston panel examining the “physician veto” and the barriers device makers face when introducing new digital health technologies into clinical environments.

Several sessions at DeviceTalks Boston will address the challenges and opportunities of Connected Health including a keynote interview with Ashley McEvoy, CEO of Insulet, as well as presentations by Philips, Baxter and others.

The episode also features a wide-ranging conversation with Mullings Group leaders Mike Moore and Holly Scott about the strength of the Massachusetts medtech ecosystem, the growth of surgical robotics, and the importance of conferences in building meaningful industry relationships.

If you want to join us at DeviceTalks Boston, you can register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the price of registration.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:03:40) - Mike Moore of The Mulling Group and Tom interview Christian Howell, CEO of Cognito Therapeutics
(00:15:40) - Holly Scott of the Mullings Group and Tom interview Sarah Matt, MD, author of The Borderless Healthcare Revolution
(00:22:30) - Holly, Mike and Tom breakdown the components of DeviceTalks Boston and the Massachusetts MedTech industry

In this episode of DeviceTalks Weekly, Tom Salemi talks with Wayne Allen, the co-founder and CEO of Perfuze, an Irish company developing a novel new way of blood clot aspiration. Allen and his co-founder already executed one successful exit earlier in their careers. Can they find success again with Perfuze?

This episode is sponsored by DeviceTalks Boston. Go to Boston.DeviceTalks.com to register. Use the code DTW25 to save 25%.

MassDevice Editor Chris Newmarker opens up the podcast with this week’s top stories from the pages of MassDevice – Masimo, Danaher, ResMed, Johnson & Johnson MedTech, and Medtronic.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:02:00) - Quick recap of DeviceTalks Minnesota
(00:07:05) - MassDevice’s Orthopedic Device Companies Special Report for 2026
(00:08:20) - Masimo shareholders give green light to $10B acquisition by Danaher
(00:09:56) - ResMed enters merger agreement to acquire Noctrix Health for $340 million
(00:14:03) - Johnson & Johnson says Ottava surgical robot met endpoints in pivotal bariatric surgery study
(00:15:45) - Medtronic merges Cardiac Surgery, Aortic units into Cardiovascular Surgery business
(00:19:45) - FOMO Studio – Yossi Bar, CEO, LEM Surgical
(00:31:22) - Keynote Interview- Wayne Allen, CEO, Perfuze

In this episode, Host Tom Salemi and Holly Scott, senior partner at The Mullings Group, preview the upcoming DeviceTalks Minnesota agenda. Join us on May 4 at the McNamara Alumni Center!

If you haven’t registered, use the code DTW25 to save 25% off the price of registration, visit https://minnesota.devicetalks.com/.

MassDevice Editor Chris Newmarker also delivers this week’s top newsmakers on the pages of MassDevice—HRS 2026, Johnson & Johnson, Stryker, Medtronic, and Teleflex.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:07:25) - The top cardiac tech stories out of HRS 2026
(00:09:03) - Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse
(00:10:16) - Stryker results miss after Q1 cyberattack; company sticks with guidance
(00:11:43) - Medtronic discloses cybersecurity breach in certain IT systems
(00:15:30) - Teleflex picks Medtronic Coronary & Renal Denervation leader Weidman as new CEO

In this episode of the DeviceTalks Weekly Podcast, SetPoint Medical CEO Murthy Simhambhatla gives listeners an audio glimpse of what attendees at DeviceTalks Minnesota will hear during the Bringing NeuroTechnologies to New Markets panel.

As he explains in this interview, Simhambhatla—an experienced MedTech executive—was initially skeptical of SetPoint’s potential after being invited to lead the company. But the more he read, the more he became convinced the vagal stimulator could help fight inflammation. “Cytokines don’t lie,” he said. Today, SetPoint Medical has FDA approval, is building a commercial plan, and is considering future financing, including a possible IPO.

This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to see the agenda. Remember to use the code DTM25 to save 25% on new registrations.

We also get a visit to our FOMO Studios from Saul Marquez, CEO of Outcome Rocket, a market research and end-to-end marketing execution agency that helps medtech and health tech organizations grow their impact and accelerate growth. See more and download the report we discuss here: https://www.outcomesrocket.com/

Finally, MassDevice Editor Chris Newmarker shares this week’s top newsmakers from MassDevice—Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Pulnovo, and CathWorks.

***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:09:23) - 5 next-gen heart valve replacement companies you need to know
(00:11:35) - Abbott completes enrollment in IVL study
(00:13:50) - Johnson & Johnson MedTech to launch new AI module for EP mapping
(00:15:10) - Johnson & Johnson MedTech to launch new AI module for EP mapping
(00:17:12) - Medtronic leads $100M financing for artery denervation tech developer Pulnovo Medical
(00:23:34) - FOMO Studio: Saul Marquez, CEO, Outcomes Rocket
(00:38:19) - Keynote Conversation: SetPoint Medical CEO Murthy Simhambhatla